Straits Times Index
3,301.75 -1.91 (-0.06%) Nikkei
38,199.10 +19.64 (+0.05%) Hang Seng
19,103.74 -11.32 (-0.06%) FTSE 100
8,414.99 -18.77 (-0.22%) Bitcoin USD
62,469.99 +1,462.88 (+2.40%) CMC Crypto 200
1,289.03 +28.83 (+2.29%)
INO Jan 2025 2.000 call
| Previous close | 0.1800 |
| Open | 0.1800 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.1800 - 0.1800 |
| Contract range | N/A |
| Volume | |
| Open interest | 830 |
PR NewswireINOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2024 and provided an update on recent company developments.
- PR Newswire
INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the "Inducement Plan").
- PR Newswire
INOVIO to Participate in Upcoming Investor Conferences in May
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of May:
